Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1993 | 12-1992 | 12-1991 | 12-1990 | 12-1989 | |
| Operating Expenses | 2,071 | 1,629 | 519 | 340 | 340 |
| Operating Income | -2,071 | -1,629 | -519 | -340 | -340 |
| Other Income | 51 | 0 | 17 | 14 | 14 |
| Pre-tax Income | -2,020 | -1,629 | -502 | -327 | -327 |
| Net Income Continuous | -2,020 | -1,629 | -502 | -327 | -327 |
| Net Income | $-2,020 | $-1,629 | $-502 | $-327 | $-327 |
| EPS Basic Total Ops | -97.58 | -133.50 | -61.96 | -61.64 | -61.64 |
| EPS Basic Continuous Ops | -97.58 | -133.50 | -61.96 | -61.64 | -61.64 |
| EPS Diluted Total Ops | -97.58 | -133.50 | -61.96 | -61.64 | -61.64 |
| EPS Diluted Continuous Ops | -97.58 | -133.50 | -61.96 | -61.64 | -61.64 |
| EBITDA(a) | $-2,067 | $-1,627 | $-519 | $-340 | $-340 |